Inspire Medical Systems
Inspire Medical Systems Inc is an American medical technology company developing minimally invasive neurostimulation therapies for obstructive sleep apnea. The company manufactures and markets the Inspire system, a closed-loop neurostimulation technology that delivers mild stimulation to the hypoglossal nerve to maintain airway openness during sleep. Revenue is derived primarily from direct sales of implantable neurostimulators, sensing leads, and programmer devices to hospital surgical centers and outpatient clinics. Core end markets encompass ENT surgical practices, sleep medicine clinics, ambulatory surgery centers, and adult sleep apnea patients across the United States, Europe, and Asia-Pacific. Inspire Medical Systems holds the market-leading pioneer position globally in FDA-approved neurostimulation therapies for obstructive sleep apnea. The corporation is headquartered in Golden Valley, Minnesota, and its common stock trades on the New York Stock Exchange.
3 of the funds FundTelligence covers report a position in Inspire Medical Systems.
- Legal name
- Inspire Medical Systems Inc
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 3
Funds holding Inspire Medical Systems
- Handelsbanken Global SMB Index Criteria — Handelsbanken · 0.03 % (full portfolio disclosed, October 2026)
- DNB Global Enhanced Small Cap — DNB · 0.02 % (full portfolio disclosed, September 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.01 % (partially disclosed portfolio, June 2026)